Remedium Capital Partners, LLC VC / PE / Holdco

Location: Fort Lauderdale, FL

CIK: 0002104501 · Show all filings

Period: Q4 2025 (Next →)

Filing Date: Feb 12, 2026

Total Value: $170M

Holdings (6)

SYRE Spyre Therapeutics Inc 28.0%

Value $47.71M Shares 1,456,231 Est. Cost $26.13 Unrealized 0.0%

ORKA Oruka Therapeutics Inc 27.6%

Value $47.05M Shares 1,552,414 Est. Cost $27.86 Unrealized 0.0%

APGE Apogee Therapeutics Inc 25.9%

Value $44.05M Shares 583,591 Est. Cost $62.99 Unrealized 0.0%

JBIO Jade Biosciences Inc 14.3%

Value $24.34M Shares 1,577,750 Est. Cost $11.73 Unrealized 0.0%

— Crescent Biopharma Inc 2.5%

Value $4.284M Shares 361,250 Est. Cost $11.86 Unrealized —

GLTO Galecto Inc 1.6%

Value $2.772M Shares 120,473 Est. Cost $17.38 Unrealized 0.0%

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
SYRE	Spyre Therapeutics Inc	1,456,231	$47.71M	28.0%	$26.13	0.0%	—	00773J202
ORKA	Oruka Therapeutics Inc	1,552,414	$47.05M	27.6%	$27.86	0.0%	—	687604108
APGE	Apogee Therapeutics Inc	583,591	$44.05M	25.9%	$62.99	0.0%	—	03770N101
JBIO	Jade Biosciences Inc	1,577,750	$24.34M	14.3%	$11.73	0.0%	—	008064206
—	Crescent Biopharma Inc	361,250	$4.284M	2.5%	$11.86	—	—	38000Q201
GLTO	Galecto Inc	120,473	$2.772M	1.6%	$17.38	0.0%	—	36322Q206